Amphion Innovations

March 4, 2009
Amphion Innovations plc Notice of Prelim Results
Amphion Innovations plc (LSE: AMP), which builds shareholder value in high growth companies in the medical and technology sectors, will announce its Prelim results for the year ending 31 December 2008 on Monday 16 March 2009.

February 27, 2009
Amphion Innovations Director Dealings
Distribution to Board Members

February 27, 2009
Amphion Innovations plc Partner Company, AXCESS International, Wins $3.5 million Port Infrastructure Award

January 30, 2009
Amphion Innovations plc Funding Update

January 19, 2009
Amphion Innovations plc Full Year Trading Update

December 31, 2008
Amphion Innovations plc Raises £1,857,900

November 27, 2008
Amphion Innovations plc Partner Company, DataTern, Signs Third IP License Agreement

October 23, 2008
Amphion Innovations plc Director/PDMR Shareholding

October 17, 2008
Amphion Innovations plc Partner Company DataTern Signs IP License Agreement with VISA

September 16, 2008
Amphion Innovations plc Directors Dealings
Board Members receive shares in lieu of fees

August 18, 2008
Amphion Innovations plc Interim Results
Interims Results for the 6 months to 30 June 2007, 35.7% increase in Net Asset Value per Share Strong Partner Company progress

June 12, 2008
Amphion Innovations plc AGM Statement

June 10, 2008
Amphion Innovations plc Partner Company DataTern Announces Agreement of First IP License

May 27, 2008
Amphion Innovations plc Partner Company Durham Scientific Crystals, Ltd. Closes £1.6 million Fundraising

April 8, 2008
Amphion’s Partner Company, Myconostica Ltd.,
Closes Further £3.9 Million Round Financing

April 7, 2008
Amphion Innovations plc
Fundraising and Directors Dealings

March 26, 2008
Amphion Innovations plc Director Shareholdings
Richard Morgan, CEO, Purchases Shares

March 13, 2008
Amphion Innovations plc Preliminary Results
Increase in Net Asset Value per share reflects continued growth of Partner Companies
225k PDF

March 3, 2008
Amphion’s New Partner Company, PrivateMarkets Inc.
Completes $3.75 million Series A Financing

February 27, 2008
Amphion Innovations plc
Notice of Preliminary Results – 13 March 2008

January 17, 2008
Amphion Innovations plc Trading Update

January 7, 2008
Amphion Partner Company, Directors Dealings
Board members receive shares in lieu of fees

December 03, 2007
Amphion Partner Company, Durham Scientific Crystals, signs Airport Security Deal
World-leading technology to revolutionise airport security Technology to reduce terrorist threat and speed up check-in process

November 12, 2007
Amphion Innovations plc
Subscription of 2,272,728 New Ordinary Shares

November 05, 2007
Amphion Innovations plc Result of EGM

October 29, 2007
Amphion Partner Company, WellGen Inc., Completes $9.5 million Series C Financing

October 12, 2007
Amphion Innovations plc
Proposed Issue of 15,909,077 New Ordinary Shares and Notice of Extraordinary General Meeting

September 12, 2007
Amphion Innovations plc
Interim Results show 35.7% increase in Net Asset Value per Share and Strong Partner Company Progress

August 28, 2007
Interims to be Released on 12 September 2007

August 22, 2007
Amphion Innovations plc Change of Adviser

August 16, 2007
Amphion Innovations plc Website

August 14, 2007
Amphion Innovations plc Partner Company Durham Scientific Crystals Ltd. Closes £3.5 million Fundraising

July 30, 2007
Amphion Innovations Partner Company Myconostica Limited Closes £570,000 Round Financing

July 12, 2007
Amphion Innovations plc Partner Company, WellGen, Inc. Announces Patent Awarded for WG0401, An Enriched Black-Tea Extract with Inflammation-Fighting Properties

July 2, 2007
Amphion Innovations plc £2.1m Placing

June 7, 2007
Amphion Innovations plc AGM Statement

April 30, 2007
Amphion Innovations plc Director Shareholdings - Richard Morgan, CEO Purchases Shares

April 11, 2007
Amphion Innovations plc Partner Company WellGen Completes Human Study Paving Way for Nutrigenomics to Play Important Role in Mainstream Product Development

April 5, 2007
Amphion Innovations Partner Company Motif BioSciences Closes $1m Financing

March 23, 2007
Port of Barbados Selects Axcess to Provide Security Systems for the Cricket World Cup 2007

March 15, 2007
Amphion Innovations plc Preliminary Results
33% Increase In Net Asset Value Per Share Reflects Strong Progress with Partner Companies.
174k PDF

February 26, 2007
Amphion Innovations plc, the developer of technology and life sciences businesses will report its preliminary results for the year ending 31 December 2006 on Thursday 15 March 2007

February 9, 2007
Amphion Innovations Partner Company Durham Scientific Crystals Closes £1.6m Round Financing

January 16, 2007
Amphion Innovations, plc Trading Update

January 16, 2007
Amphion Innovations, plc Creation of a Gulf-based Joint Venture

January 5, 2007
Amphion Innovations, plc Fundraising

November 20, 2006
Amphion Innovations plc Acquires 35% Stake In University of Manchester Molecular Diagnostic Spin-Out Company

November 13, 2006
Amphion Innovations plc Partner Company Supertron Acquires Spin Systems

November 7, 2006
Amphion Innovations Partner Company Durham Scientific Crystals Closes £875,000 Financing

September 14, 2006
Amphion Innovations plc Partner Company WellGen Appoints Dr Kathleen Mullinix as New CEO

September 12, 2006
Amphion Innovations plc Change of NOMAD and Broker

September 07, 2006
Amphion Innovations plc Interim Results Show 21 Percent Gain in Fair Value of Investments

August 22, 2006
FireStar Software, Inc. Raises Additional $2 Million

August 09, 2006
Amphion Innovations Placing Raising £1,032,800

July 24, 2006
Amphion Innovations Partner Company Supertron Raises $3.5 Million In Series C Financing

June 8, 2006
Amphion Innovations Names Zaki Hosny of Merck and Company CEO of Partner Company Motif BioSciences

June 8, 2006
Amphion Innovations plc Annual General Meeting — Trading Update

June 6, 2006
Amphion Innovations plc Signs Memorandum of Understanding with University of Manchester Spinout Myconostica Ltd.

June 1, 2006
Posting of Annual Report and Accounts
Amphion has posted its 2005 Annual Report and Accounts. Copies of these accounts and the notice convening the AGM have been sent to shareholders by post and are available at the Company's website at http://www.amphionplc.com. The 2006 Annual General Meeting will be held on 8 June 2006 at noon at the offices of Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London WC2A 1PB.

March 15, 2006
Amphion Innovations plc Partner Company AXCESS International Completes $2.3M Funding

March 8, 2006
2006 Preliminary Results
Preliminary Results Show 24% Increase In Net Asset Value Per Share Over Four Months Since IPO
169k PDF

March 2, 2006
Amphion Innovations plc Partner Company Motif BioSciences Announces Completion of $1.875 Million Financing and Commencement of Arabian Gulf Sampling Program

February 16, 2006
WellGen, Inc., Leading Nutrigenomics Company, Completes $3M Series B Financing

January 3, 2006
Additional Investment in Portfolio Companies

December 5, 2005
Amphion Innovations Announces Further Investment

November 8, 2005
WellGen Taps Arthur H. Finnel, Food and Biotech Industry Veteran, To Be New Chief Financial Officer

October 10, 2005
Amphion Innovations Acquires a 30% stake in Medical Imaging Company

September 21, 2005
Amphion Innovations acquires 29% stake in award winning Durham University spin-out company

August 30, 2005
Amphion Innovations Invests Additional $1M in Leading Nutrigenomics Company, WellGen, Inc.

August 23, 2005
Amphion Innovations - Admission to trading on AIM
Amphion Innovations PLC (“Amphion”), a developer of life sciences companies, announces that trading in the Company’s shares will commence today on the AIM market of the London Stock Exchange at 08.00 under the ticker symbol AMP.
20k PDF

August 22, 2005
Amphion Innovations Completes IPO

August 16, 2005
Intention to Float

Regulatory Releases

Disclaimer | Sitemap